Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Tel Aviv Stock Exchange (TASE) is the sole public securities exchange in Israel and serves as a vital financial hub for the nation's robust life sciences and biotechnology sectors. Through its TASE Indexes department, the exchange manages the TA-Biomed Index, a benchmark that tracks the performance of listed companies involved in medical research, pharmaceutical development, and medical device manufacturing. TASE provides a platform for capital raising and secondary offerings, supporting the growth of Israeli healthcare companies from early-stage R&D to global commercialization. Many Israeli biotech firms choose TASE for their initial public offerings or as a dual-listing venue alongside NASDAQ to access local and international investor bases. The exchange facilitates liquidity and transparency for a diverse range of healthcare-related securities, making it a cornerstone of the Israeli med-tech ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TASE Indexes.